Kidney Measures with Diabetes and Hypertension on Cardiovascular Disease: The Atherosclerosis Risk in Communities Study

被引:17
作者
Alexander, Nadine [1 ]
Matsushita, Kunihiro [1 ]
Sang, Yingying [1 ]
Ballew, Shoshana [1 ]
Mahmoodi, Bakhtawar K. [4 ]
Astor, Brad C. [2 ,3 ]
Coresh, Josef [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[2] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[3] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands
关键词
Chronic kidney disease; Diabetes; Hypertension; Cardiovascular disease; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; BLOOD-PRESSURE; RANDOMIZED-TRIAL; MORTALITY; EQUATION; STROKE; ASSOCIATIONS; INDIVIDUALS; CREATININE;
D O I
10.1159/000433450
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Whether the association of chronic kidney disease (CKD) with cardiovascular risk differs based on diabetes mellitus (DM) and hypertension (HTN) status remains unanswered. Methods: We investigated 11,050 participants from the Atherosclerosis Risk in Communities Study (fourth examination (1996-1998)) with follow-up for cardiovascular outcomes (coronary disease, heart failure and stroke) through 2009. Using the Cox regression models, we quantified cardiovascular risk associated with estimated glomerular filtration rate (eGFR) and urinary albumin-to-creatinine ratio (ACR) in individuals with and without DM and/or HTN and assessed their interactions. Results: Individuals with DM and HTN generally had higher cardiovascular risk relative to those without at all the levels of eGFR and ACR. Cardiovascular risk increased with lower eGFR and higher ACR regardless of DM and HTN status (e.g. adjusted hazards ratio (HR) for eGFR 30-44 vs. 90-104 ml/min/1.73 m(2), 2.32 (95% CI, 1.66-3.26) in non-diabetics vs. 1.83 (1.25-2.67) in diabetics and 2.45 (2.20-5.01) in non-hypertensives vs. 1.51 (1.27-1.81) in hypertensives and corresponding adjusted HR for ACR 30-299 vs. <10 mg/g, 1.70 (1.45-2.00) vs. 1.34 (1.10-1.64) and 1.42 (1.10-1.85) vs. 1.57 (1.36-1.81), respectively). Only the ACR-DM interaction reached significance, with a shallower relative risk gradient among diabetics than among non-diabetics (p = 0.02). Analysis of individual cardiovascular outcomes showed similar results. Conclusion: Although individuals with DM and HTN generally had higher cardiovascular risk relative to those without these complications, both low eGFR and high ACR were associated with cardiovascular diseases regardless of the presence or absence of DM and HTN. These findings reinforce the importance of CKD in cardiovascular outcomes. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:409 / 417
页数:9
相关论文
共 50 条
  • [21] The Association of Sport and Exercise Activities With Cardiovascular Disease Risk: The Atherosclerosis Risk in Communities (ARIC) Study
    Porter, Anna K.
    Schilsky, Samantha
    Evenson, Kelly R.
    Florido, Roberta
    Palta, Priya
    Holliday, Katelyn M.
    Folsom, Aaron R.
    [J]. JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2019, 16 (09) : 698 - 705
  • [22] Cognition impairment and risk of subclinical cardiovascular disease in older adults: The atherosclerosis risk in communities study
    Li, Dongze
    Jia, Yu
    Yu, Jing
    Liu, Yi
    Li, Fanghui
    Zhang, Wei
    Gao, Yongli
    Liao, Xiaoyang
    Wan, Zhi
    Zeng, Zhi
    Zeng, Rui
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [23] Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study
    Wong, Nathan D.
    Zhao, Yanglu
    Patel, Rohini
    Patao, Christopher
    Malik, Shaista
    Bertoni, Alain G.
    Correa, Adolfo
    Folsom, Aaron R.
    Kachroo, Sumesh
    Mukherjee, Jayanti
    Taylor, Herman
    Selvin, Elizabeth
    [J]. DIABETES CARE, 2016, 39 (05) : 668 - 676
  • [24] Integrated proteomic and metabolomic modules identified as biomarkers of mortality in the Atherosclerosis Risk in Communities study and the African American Study of Kidney Disease and Hypertension
    Zhou, Linda
    Surapaneni, Aditya
    Rhee, Eugene P.
    Yu, Bing
    Boerwinkle, Eric
    Coresh, Josef
    Grams, Morgan E.
    Schlosser, Pascal
    [J]. HUMAN GENOMICS, 2022, 16 (01)
  • [25] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    Jose J. G. De Lima
    Luis Henrique W. Gowdak
    Elias David-Neto
    Luiz A. Bortolotto
    [J]. High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 159 - 165
  • [26] Vital Exhaustion and Retinal Microvascular Changes in Cardiovascular Disease: Atherosclerosis Risk in Communities Study
    Cheung, Ning
    Rogers, Sophie
    Mosley, Thomas H.
    Klein, Ronald
    Couper, David
    Wong, Tien Y.
    [J]. PSYCHOSOMATIC MEDICINE, 2009, 71 (03): : 308 - 312
  • [27] Impact of Hypertension and Subclinical Organ Damage on the Incidence of Cardiovascular Disease Among Japanese Residents at the Population and Individual Levels - The Circulatory Risk in Communities Study (CIRCS) -
    Kitamura, Akihiko
    Yamagishi, Kazumasa
    Imano, Hironori
    Kiyama, Masahiko
    Cui, Renzhe
    Ohira, Tetsuya
    Umesawa, Mitsumasa
    Muraki, Isao
    Sankai, Tomoko
    Saito, Isao
    Iso, Hiroyasu
    [J]. CIRCULATION JOURNAL, 2017, 81 (07) : 1022 - +
  • [28] Chronic kidney disease measures for cardiovascular risk prediction
    Mok, Yejin
    Ballew, Shoshana H.
    Matsushita, Kunihiro
    [J]. ATHEROSCLEROSIS, 2021, 335 : 110 - 118
  • [29] Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study
    Yao, Lu
    Folsom, Aaron R.
    Pankow, James S.
    Selvin, Elizabeth
    Michos, Erin D.
    Alonso, Alvaro
    Tang, Weihong
    Lutsey, Pamela L.
    [J]. JOURNAL OF HYPERTENSION, 2016, 34 (02) : 196 - 203
  • [30] Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: a pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study
    Imai, Yukiko
    Hirata, Takumi
    Saitoh, Shigeyuki
    Ninomiya, Toshiharu
    Miyamoto, Yoshihiro
    Ohnishi, Hirofumi
    Murakami, Yoshitaka
    Iso, Hiroyasu
    Tanaka, Sachiko
    Miura, Katsuyuki
    Tamakoshi, Akiko
    Yamada, Michiko
    Kiyama, Masahiko
    Ueshima, Hirotsugu
    Ishikawa, Shizukiyo
    Okamura, Tomonori
    [J]. HYPERTENSION RESEARCH, 2020, 43 (12) : 1437 - 1444